VANCOUVER, BRITISH COLUMBIA--(Marketwire - Feb. 19, 2008) - ALDA Pharmaceuticals Corp. (TSX VENTURE:APH) (“ALDA”) is pleased to announce that the United States Patent and Trademark Office (“USPTO”) has provided ALDA with an “Issue Notification” stating that US Patent Application No. 10/525,110 is projected to be issued on March 4, 2008 as U.S. Patent No. 7,338,927. The patent provides protection for the composition and production methods for ALDA’s T36® formulation.
